Azurity Pharmaceuticals, Inc. recalls Eprontia (topiramate) oral solution
FDA Class III
FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).
- Hazard
- Failed Impurities/Degradation Specifications: Out of specification Impurity C (4,5-desisopropylidene topiramate) result observed during routine stability testing at 18 months.
- Products
-
- Eprontia (topiramate) oral solution
- Where it was sold
-
USA nationwide.
Nationwide
- Units affected
- 2,220 bottles
- About this recall
- Eprontia (topiramate) oral solution, 25 mg/mL, 473 mL Bottle, Rx only, Manufactured for: Azurity Pharmaceuticals, Woburn, MA 01801, NDC 52652-9001-1